Adicet Bio (ACET) Short Interest Ratio & Short Volume → Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report (From Darwin) (Ad) Free ACET Stock Alerts $2.02 -0.25 (-10.99%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Adicet Bio Short Interest DataCurrent Short Volume7,690,000 sharesPrevious Short Volume5,810,000 sharesChange Vs. Previous Month+32.36%Dollar Volume Sold Short$18.07 millionShort Interest Ratio / Days to Cover4.6Last Record DateMarch 31, 2024Outstanding Shares82,170,000 sharesPercentage of Shares Shorted9.36%Today's Trading Volume929,963 sharesAverage Trading Volume1,583,169 sharesToday's Volume Vs. Average59% Short Selling Adicet Bio ? Sign up to receive the latest short interest report for Adicet Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatACET Short Interest Over TimeACET Days to Cover Over TimeACET Percentage of Float Shorted Over Time Ad DTISpecial FREE offer on stock hotsheetsThese sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?Click here and I’ll show you Adicet Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20247,690,000 shares $18.07 million +32.4%N/A4.6 $2.35 3/15/20245,810,000 shares $11.62 million +2.7%N/A3.4 $2.00 2/29/20245,660,000 shares $13.30 million +19.2%N/A3.7 $2.35 2/15/20244,750,000 shares $14.25 million +22.1%N/A3.4 $3.00 1/31/20243,890,000 shares $11.63 million +21.2%N/A3.4 $2.99 1/15/20243,210,000 shares $10.69 million +21.1%10.6%3.8 $3.33 Get the Latest News and Ratings for ACET and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adicet Bio and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,650,000 shares $5.01 million +4.7%8.7%4.3 $1.89 12/15/20232,530,000 shares $4.02 million -18.9%8.3%6.4 $1.59 11/30/20233,120,000 shares $3.68 million +3.0%10.3%8.4 $1.18 11/15/20233,030,000 shares $3.67 million +6.7%10.0%7.7 $1.21 10/31/20232,840,000 shares $3.75 million -5.7%9.5%6.5 $1.32 10/15/20233,010,000 shares $4.15 million +0.3%10.0%6.6 $1.38 9/30/20233,000,000 shares $4.11 million +2.4%10.0%6.1 $1.37 9/15/20232,930,000 shares $5.01 million +8.5%9.7%3.3 $1.71 8/31/20232,700,000 shares $5.40 million +9.3%9.0%2.9 $2.00 8/15/20232,470,000 shares $5.26 million +7.4%8.2%2.7 $2.13 7/31/20232,300,000 shares $6.14 million -22.3%7.4%2.6 $2.67 7/15/20232,960,000 shares $9.12 million -5.7%9.6%3.5 $3.08 6/30/20233,140,000 shares $7.63 million -12.3%10.2%3.8 $2.43 6/15/20233,580,000 shares $16.22 million +15.1%12.0%8.2 $4.53 5/31/20233,110,000 shares $17.04 million +6.1%10.4%6.7 $5.48 5/15/20232,930,000 shares $20.89 million -7.6%9.8%6.2 $7.13 4/30/20233,170,000 shares $18.51 million +16.1%11.4%6.6 $5.84 4/15/20232,730,000 shares $15.32 million -2.9%9.1%5.5 $5.61 3/31/20232,810,000 shares $16.19 million -7.6%9.4%5.3 $5.76 3/15/20233,040,000 shares $23.44 million -7.6%10.2%5.4 $7.71 2/28/20233,290,000 shares $25.93 million -4.1%11.0%4.7 $7.88 2/15/20233,430,000 shares $27.92 million +7.9%11.5%4.8 $8.14 1/31/20233,180,000 shares $29.10 million -15.2%11.0%4.2 $9.15 1/15/20233,750,000 shares $32.59 million -1.8%12.9%4.9 $8.69 12/30/20223,820,000 shares $34.15 million -6.8%13.1%5.1 $8.94 12/15/20224,100,000 shares $40.80 million +2.0%14.1%5.5 $9.95 11/30/20224,020,000 shares $73.08 million +29.7%14.2%6.7 $18.18 11/15/20223,100,000 shares $63.05 million -13.7%11.0%5.6 $20.34 10/31/20223,590,000 shares $59.20 million -4.8%13.6%6.5 $16.49 10/15/20223,770,000 shares $62.62 million -4.8%14.2%7.2 $16.61 9/30/20223,960,000 shares $56.31 million +30.3%15.0%7.6 $14.22 9/15/20223,040,000 shares $52.08 million +8.2%11.5%6 $17.13 8/31/20222,810,000 shares $39.79 million +10.6%11.7%5.8 $14.16 8/15/20222,540,000 shares $38.96 million -51.3%10.6%4 $15.34Special FREE offer on stock hotsheets (Ad)These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?Click here and I’ll show you ACET Short Interest - Frequently Asked Questions What is Adicet Bio's current short interest? Short interest is the volume of Adicet Bio shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 7,690,000 shares of ACET short. Learn More on Adicet Bio's current short interest. What is a good short interest ratio for Adicet Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACET shares currently have a short interest ratio of 5.0. Learn More on Adicet Bio's short interest ratio. Which institutional investors are shorting Adicet Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adicet Bio: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Adicet Bio's short interest increasing or decreasing? Adicet Bio saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 7,690,000 shares, an increase of 32.4% from the previous total of 5,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Adicet Bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Adicet Bio: Veru Inc. (6.77%), Trevi Therapeutics, Inc. (1.51%), Inventiva S.A. (0.11%), Gossamer Bio, Inc. (4.77%), Greenwich LifeSciences, Inc. (2.41%), Capricor Therapeutics Inc (11.11%), Alimera Sciences, Inc. (0.21%), 23andMe Holding Co. (11.72%), scPharmaceuticals Inc. (19.70%), Regulus Therapeutics Inc. (9.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Adicet Bio stock? Short selling ACET is an investing strategy that aims to generate trading profit from Adicet Bio as its price is falling. ACET shares are trading down $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adicet Bio? A short squeeze for Adicet Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACET, which in turn drives the price of the stock up even further. How often is Adicet Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACET, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: VERU Short Interest Data TRVI Short Interest Data IVA Short Interest Data GOSS Short Interest Data GLSI Short Interest Data CAPR Short Interest Data ALIM Short Interest Data ME Short Interest Data SCPH Short Interest Data RGLS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACET) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing